Translational medicine and the human microbiome
- Rob Knight1
© Knight; licensee BioMed Central Ltd. 2010
Published: 11 October 2010
We have learned much about the human microbiome, especially with advances in sequencing. However, as with the human genome, translating this knowledge into therapies remains challenging. One key advantage of focusing on the microbiome is that, outside of Star Trek, our genomes change little during our lifetime, yet each of our microbiomes has changed profoundly. Our microbiomes develop from an undifferentiated state that is dependent on delivery mode (i.e. vaginal delivery versus C-section) to the highly distinct communities that populate every crevice of our bodies.
Here I discuss the variation in the human microbiome within and between people, with a focus on the importance of spatially and temporally resolved studies, and the use of animal models, to gain insight into the role of microbes in obesity. Interestingly, many features of the microbiota of humans can be transferred into mice. The prospects for building a translational medicine pipeline, in which a single stool sample can be used to predict which interventions will work for which person, are compelling.
This article is published under license to BioMed Central Ltd.